Publikation

FUSE-ML: development and external validation of a clinical prediction model for mid-term outcomes after lumbar spinal fusion for degenerative disease.

Wissenschaftlicher Artikel/Review - 21.02.2022

Bereiche
PubMed
DOI
Kontakt

Zitation
Staartjes V, Stumpo V, Ricciardi L, Maldaner N, Eversdijk H, Vieli M, Ciobanu-Caraus O, Raco A, Miscusi M, Perna A, Proietti L, Lofrese G, Dughiero M, Cultrera F, Nicassio N, An S, Ha Y, Amelot A, Alcobendas I, Viñuela-Prieto J, Gandía-González M, Girod P, Lener S, Kögl N, Abramovic A, Safa N, Laux C, Farshad M, O'Riordan D, Loibl M, Mannion A, Scerrati A, Molliqaj G, Tessitore E, Schröder M, Vandertop W, Stienen M, Regli L, Serra C. FUSE-ML: development and external validation of a clinical prediction model for mid-term outcomes after lumbar spinal fusion for degenerative disease. Eur Spine J 2022; 31:2629-2638.
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
Eur Spine J 2022; 31
Veröffentlichungsdatum
21.02.2022
eISSN (Online)
1432-0932
Seiten
2629-2638
Kurzbeschreibung/Zielsetzung

Indications and outcomes in lumbar spinal fusion for degenerative disease are notoriously heterogenous. Selected subsets of patients show remarkable benefit. However, their objective identification is often difficult. Decision-making may be improved with reliable prediction of long-term outcomes for each individual patient, improving patient selection and avoiding ineffective procedures.